Home
About
Overview
Sharing Data
ORCID
Help
History (58)
Manipulation of Interleukin-1? and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence.
Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
Cell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARM.
PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light.
See All 58 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light.
Maron BJ, Maron MS. PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light. J Am Coll Cardiol. 2020 07 14; 76(2):198-200.
View in:
PubMed
subject areas
AMP-Activated Protein Kinases
Cardiomyopathies
Glycogen Storage Disease
Humans
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD